跳至主要内容
临床试验/NCT06567483
NCT06567483已完成不适用

A Comparison of Protein-bound and Large Molecular Weight Uremic Toxin Removals With Novel Super High-flux Dialyzer Between Hemodialysis and High Volume Online Hemodiafiltration Modalities : A Crossover Randomized Controlled Study

Chulalongkorn University2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Protein bound uremic toxin reduction ratio (percent)

研究概览

简要总结

The goal of this prospective, randomized, crossover study is to study about using super high-flux dialyzer in the chronic hemodialysis patients.

The main questions aim to answer are the reduction ratio of protein bound uremic toxins

Participants will undergone the pre-dilution online hemodiafiltration and conventional hemodialysis for each 8 weeks followed by washout phase for 4 weeks.

详细描述

Other secondary outcomes that the researcher wants to study are

  1. The reduction ratio of Beta2microglobulin, kappa and lambda free light chain
  2. Serum albumin and dialysate albumin loss
  3. Quality of life, muscle mass and nutritional status of the patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic hemodialysis patients in King Chulalongkorn Memorial hospital
  • Residual renal function less than 100 ml/day

排除标准

  • Dialyzer allergy
  • Malnutrition requiring intradialytic parenteral nutrition
  • Cirrhosis child C or decompensated cirrhosis
  • Active uncontrolled infection
  • Active cardiovascular disease
  • Advanced stage malignancy
  • Predicted to be undergone living related kidney transplant within 1 year

结局指标

主要结局

Protein bound uremic toxin reduction ratio (percent)

时间窗: 8 weeks

The reduction ratio of indoxyl sulfate will be calculated as percent by pre and post dialysis data. The measurement will take place in the pre-dialysis of the first and the last time of intervention

次要结局

  • Beta2 microglobulin, kappa and lambda free light chain and urea reduction ratio (percent)(8 weeks)
  • Quality of life assessment in each group(8 weeks)
  • Serum albumin and dialysate albumin loss(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rossanun Shoosanglertwijit, MD

Principle investigator

Chulalongkorn University

研究点 (2)

Loading locations...

相似试验